Last week we saw some great news for our sector. The £2.5 billion British Patient Capital fund, launched by the British Business Bank, will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors and will help to build the next generation of UK life science companies to scale to global leadership.
Find out how the business and regulatory environment is changing, and hear from Department for International Trade experts based in China, from UK Life Sciences companies who have invested there and from organisations in China who can help with advice and incubation services.
The following guest blog is from Dr Jen Vanderhoven, Senior Project Manager for FUJIFILM Diosynth Biotechnologies, and Dr Mark Corbett, Network Manager for BIOCATNET, a BBSRC Network in Industrial Biotechnology and Bioenergy.
Last month saw two deals and continued strong financing in the sector with over £200m raised for UK-based businesses. Also, in this edition, we explain the UK’s tax efficient investing schemes, look at the first ICO in Europe, and meet Maven, an investor in high growth businesses.
This week I’m writing from BIO in Boston, one of the largest life science conferences of the year, where BIA has meetings, panels and networking lined up to highlight the strengths of the UK bioscience sector.
By Ian Staples, founder and chief executive of British biotechnology company Matoke Pharma. Ian discusses the need to support the vital contribution small and medium sized enterprises (SMEs) make to the fight against anti-microbial resistance
Dr Gillian Burgess, Site Head of UK Research and Vice President at Vertex Pharmaceuticals and Board Member of the Science Industry Partnership (SIP) of employers, sets out the business case for keeping up the momentum on diversity across the science industries.
Last week the government produced two reports looking at the vital statistics of the UK life sciences industry and the international competitiveness of the UK environment for life sciences businesses. Here we take a brief look at the data and pick out some interesting statistics.
Today the PM delivered a speech on the vital role AI can have in diagnosing chronic diseases and challenged the NHS, the AI sector and health charities to use data and AI to drastically improve current diagnosis capabilities to prevent 22,000 cancer deaths each year by 2033.